Bioiberica is helping formulators capitalise on the trend with a new cost-effective, clinically validated Native (undenatured) Type II Collagen under the brand name b-2Cool.
Native Type II Collagen works via a unique mechanism of action that sets it apart from other forms of collagen.
Rather than contributing to the structural integrity of the joint, Native Type II Collagen modulates the immune response through oral toleration to protect against degradation of endogenous collagen, thus reducing the inflammatory response in joints damaged by osteoarthritis, rheumatoid arthritis or extreme exertion.
b-2Cool Native Type II Collagen is produced through a unique, strictly controlled process that guarantees the biological activity of the molecule. It has been developed by Bioiberica scientists with a proven record of expertise.
The efficacy of b-2Cool has been confirmed in both animal models and clinical trials, including one published RCT to date and another RCT is expected to start in the coming months.
Bioiberica’s b-2Cool Native Type II Collagen is the first major challenger to the established leader in the US, offering brands an unrestricted alternative supported by the reputation of the worldwide joint health expert.
Bioiberica, a European biotech company based in Barcelona, has been contributing to the science of natural joint care for more than 20 years, with many of the company’s ingredients serving as the foundation for international standards.
Bioiberica’s b-2Cool is available in the US exclusively through Berg Imports (MI, USA).
For more information, contact Cai Berg at +1 734 253 2231 or email Cai@bergimports.com.